Long-term outcome after multimodality treatment for stage III thymic tumors.
about
Chemotherapy for thymic carcinoma and advanced thymoma in adultsThe clinical features, diagnosis and management of recurrent thymomaWhich stages of thymoma benefit from adjuvant chemotherapy post-thymectomy?En bloc extended total thymectomy and extrapleural pneumonectomy in Masaoka stage IVA thymomasAdjuvant Therapy for Thymic Carcinoma--A Decade of Experience in a Taiwan National Teaching HospitalCurrent chemotherapy options for thymic epithelial neoplasms.A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management.Thymic neoplasm: a rare disease with a complex clinical presentationThe role of a pseudocapsula in thymic epithelial tumors: outcome and correlation with established prognostic parameters. Results of a 20-year single centre retrospective analysis.Case Report of Thymoma Tumor Reduction Following Plasmapheresis.Radiotherapy for thymic neoplasmsPrognosis and therapeutic response according to the World Health Organization histological classification in advanced thymoma.Thymoma and thymic carcinoma.Chemotherapy and targeted agents for thymic malignancies.Surgical management of thymic epithelial tumors in children: lessons from the French Society of Pediatric Oncology and review of the literature.Is sacrifying the phrenic nerve during thymoma resection worthwhile?Multimodality treatment of stage II thymic tumours.The correlation of morphological features of chest computed tomographic scans with clinical characteristics of thymoma.Management of metastatic malignant thymoma with advanced radiation and chemotherapy techniques: report of a rare case.A Rare Tumor with a Very Rare Initial Presentation: Thymic Carcinoma as Bone Marrow Metastasis.Multimodality therapy for locally-advanced thymic epithelial tumors: where are we now?Post-operative delayed ambulation after thymectomy is associated withpre-operative six-minute walk distance.Multimodality treatment for advanced thymic carcinoma: outcomes of induction therapy followed by surgical resection in 16 cases at a single institution.Long lasting efficacy of sorafenib in a heavily pretreated patient with thymic carcinoma.Mutation analysis of the EGFR gene and its downstream signaling pathway in thymic carcinoma patients from a Chinese Han population.[Advances on diagnosis and treatment of malignant thymic tumors].Wind of change in surgical treatment of thymic tumors
P2860
Q24200260-FABC7206-B619-4981-A8A3-D2E23975750CQ27022404-88CD5C04-614D-4EA7-AC26-466A548F17FFQ34031779-67558149-AD08-4FA4-A6C4-3ABDFA414ECFQ34728029-AC4EF10B-71F1-416C-86B7-AE557C595315Q35891623-EAAADE55-FA96-4B60-9F83-19C5A40CB35BQ36163988-FE9E4715-BE50-41AD-997D-0221D4A20318Q36608677-FA8B8871-292F-4D04-9751-5F720D581EEBQ36753888-D106CE46-B41E-4ABD-8D33-C4AFC1F70C85Q37278777-2A32DAEA-02B4-4A57-96DB-91B368E20173Q37328737-68B2D625-54D9-48AF-80E3-3C1FE0B3A1DBQ37790931-44DEB8CF-2834-401A-BC6A-7AEC65CD125FQ37942084-595DD6B2-34B9-4562-9B1E-87BAD749AC9BQ37975140-22BFDE96-3752-48A8-8971-AD453B6A8450Q38010806-DF548768-BD91-4EE6-8582-36A89D7443C5Q38240633-3BE6126B-7E59-4903-B97C-0C88A354AD38Q40173286-721277D8-2ED7-4DC5-8540-CFEB3547C766Q41305733-5189847E-0C80-4A2E-848D-19D9FD53BDDBQ41665978-1B876DD9-9A14-4995-AE96-4DFEB4F6A24DQ41885775-F91DAC2B-BCAD-49E8-85E6-B2E636AA9E49Q42128379-E90C60E4-EE5E-4CFE-82D7-9F84E844565BQ42211809-7E732BAD-D70A-444F-BAD2-FFA2279DCAF5Q47917657-1756324D-CBD1-4EAD-B915-134539CFD98CQ50623322-35187F16-0557-4188-BEEC-F971E1DEFF76Q51301560-916A5DAF-5994-42B2-BACF-0754DEE385A2Q51437092-AFDDECDB-D887-47E5-B935-5DD76A0A8123Q55465359-123710DB-D769-46D4-A694-8B7428C8BCD7Q58128745-916418FB-7606-406D-81CB-3F9249C05E36
P2860
Long-term outcome after multimodality treatment for stage III thymic tumors.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Long-term outcome after multimodality treatment for stage III thymic tumors.
@en
Long-term outcome after multimodality treatment for stage III thymic tumors.
@nl
type
label
Long-term outcome after multimodality treatment for stage III thymic tumors.
@en
Long-term outcome after multimodality treatment for stage III thymic tumors.
@nl
prefLabel
Long-term outcome after multimodality treatment for stage III thymic tumors.
@en
Long-term outcome after multimodality treatment for stage III thymic tumors.
@nl
P2093
P50
P1476
Long-term outcome after multimodality treatment for stage III thymic tumors.
@en
P2093
Edoardo Mercadante
Erino A Rendina
Federico Francioni
Flavia Longo
Giorgio F Coloni
Marco Anile
P304
1866-72; discussion 1872
P356
10.1016/S0003-4975(03)01020-8
P407
P577
2003-12-01T00:00:00Z